Clinical Trials Logo

Clinical Trial Summary

This study will assess the safety and efficacy of multiple-dose of STSP-0601 for the treatment of bleeding episodes in hemophilia A or B patients with inhibitors.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05027230
Study type Interventional
Source Staidson (Beijing) Biopharmaceuticals Co., Ltd
Contact Yanli Wang
Phone +86-010-67519614
Email [email protected]
Status Not yet recruiting
Phase Phase 1/Phase 2
Start date October 2021
Completion date March 2022

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04398628 - ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Completed NCT02546622 - ATHN 2: Factor Switching Study
Unknown status NCT02433782 - Myofascial Therapy in Patients With Hemophilic Arthropathy N/A
Terminated NCT02586012 - Weight-based Dosing in Hemophilia A Phase 2
Completed NCT02165462 - Bilateral Deficit Phenomenon in Patients With Haemophilic Arthropathy N/A
Unknown status NCT02165592 - Assessment of Proprioceptive and Functional Characteristics in Patients With Hemophilia N/A
Completed NCT01232634 - Validation of Ultrasound as a Diagnostic Tool for Assessment of Hemophilic Arthropathy of Knees and Ankles Phase 2
Not yet recruiting NCT04877054 - Pilot Evaluation of a Motivational Interviewing Intervention Targeting Adherence Behaviors in Youth With Hemophilia N/A
Not yet recruiting NCT05039008 - Restricting Blood Flow in Improving Muscle Strength in Patients With Hemophilic Arthropathy N/A
Terminated NCT01191372 - First-in-Human and Proof-of-Mechanism Study of ARC19499 Administered to Hemophilia Patients Phase 1
Recruiting NCT03818529 - ATHN 8: Previously Untreated Patients (PUPs) Matter Study
Withdrawn NCT03996486 - Study to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe Hemophilia Phase 1
Completed NCT03842605 - Efficacy of Strength Training in Improving Elbow Range of Motion and Function in Adults With Hemophilia N/A
Completed NCT01708564 - A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B Phase 1
Completed NCT04206033 - Hemophilia and Bone Metabolism: Study of Monocytic Populations and Inflammatory Proteins
Terminated NCT02402829 - A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed NCT01000844 - Joint Outcome Study Continuation for Children With Severe Factor VIII Deficiency
Completed NCT03596814 - MOTHIF II : THERAPEUTIC MANAGEMENT AND USE OF CLOTTING FACTORS IN HEMOPHILIA A & B IN FRANCE II
Recruiting NCT03006965 - Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT®